- Home
- IMNN vs BNZI Comparison
IMNN vs BNZI Comparison
Compare IMNN & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- BNZI
- Stock Information
- Founded
- IMNN 1982
- BNZI 2016
- Country
- IMNN United States
- BNZI United States
- Employees
- IMNN N/A
- BNZI N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- IMNN Health Care
- BNZI
- Exchange
- IMNN Nasdaq
- BNZI Nasdaq
- Market Cap
- IMNN 12.1M
- BNZI 11.5M
- IPO Year
- IMNN 1985
- BNZI N/A
- Fundamental
- Price
- IMNN $5.75
- BNZI $2.37
- Analyst Decision
- IMNN Buy
- BNZI Strong Buy
- Analyst Count
- IMNN 2
- BNZI 1
- Target Price
- IMNN $182.61
- BNZI $240.00
- AVG Volume (30 Days)
- IMNN 55.7K
- BNZI 347.5K
- Earning Date
- IMNN 11-06-2025
- BNZI 11-13-2025
- Dividend Yield
- IMNN N/A
- BNZI N/A
- EPS Growth
- IMNN N/A
- BNZI N/A
- EPS
- IMNN N/A
- BNZI N/A
- Revenue
- IMNN N/A
- BNZI $9,021,543.00
- Revenue This Year
- IMNN N/A
- BNZI $337.60
- Revenue Next Year
- IMNN N/A
- BNZI $91.81
- P/E Ratio
- IMNN N/A
- BNZI N/A
- Revenue Growth
- IMNN N/A
- BNZI 107.94
- 52 Week Low
- IMNN $4.83
- BNZI $2.34
- 52 Week High
- IMNN $41.22
- BNZI $112.00
- Technical
- Relative Strength Index (RSI)
- IMNN 36.86
- BNZI 33.58
- Support Level
- IMNN $5.53
- BNZI $2.40
- Resistance Level
- IMNN $5.89
- BNZI $2.68
- Average True Range (ATR)
- IMNN 0.32
- BNZI 0.25
- MACD
- IMNN 0.07
- BNZI -0.01
- Stochastic Oscillator
- IMNN 23.81
- BNZI 2.58
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.